1 results match your criteria: "Pharmacy Foundation of Haarlem Hospitals. Haarlem (The Netherlands). mbecker@sahz.nl.[Affiliation]"
Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study.
Pharm Pract (Granada)
June 2020
PharmD, PhD. Hospital Pharmacist, Researcher, Pharmacy Foundation of Haarlem Hospitals. Haarlem (The Netherlands).
Background: In dual antiplatelet therapy (DAPT), low-dose acetylsalicylic acid is combined with a P2Y12 inhibitor. However, combining antithrombotic agents increases the risk of bleeding. Guidelines on DAPT recommend using this combination for a limited period of between three weeks and 30 months.
View Article and Find Full Text PDF